1. Home
  2. Pharma & Healthcare
  3. Global Vaccines Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Vaccines Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 135 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Vaccines market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Vaccines market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Vaccines in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
Recombinant Vaccines
Viral Vaccines
Polysaccharide Vaccines
Others

Market Snapshot, By Application
Cholera
Hepatitis B
Diphtheria
Tetanus
Measles Vaccine
Hepatitis A
Live Attenuated Influenza Vaccine
Polio Vaccine
Rabies Vaccine

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
GSK
Tiantan
Sanofi
Pfizer
Novartis(GSK)
Merck
MedImmune LLC
Kangtai
Jintan
J&J(Crucell)
Hualan
Hissen
CSL
China National Biotec

The study objectives of this report are:
To study and analyze the global Vaccines market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Vaccines manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Vaccines market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Vaccines are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Vaccines Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Vaccines Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Vaccines

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Vaccines Sales Channel and Distributors Analysis
3.3.1 Vaccines Sales Channel
3.3.2 Vaccines Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Vaccines Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Vaccines Type Introduction
4.1.1 Recombinant Vaccines
4.1.2 Viral Vaccines
4.1.3 Polysaccharide Vaccines
4.1.4 Others
4.2 Global Vaccines Sales by Type 2016-2021
4.3 Global Vaccines Revenue by Type 2016-2021
4.4 Global Vaccines Price by Type 2016-2021

5 Market Segment: by Application
5.1 Vaccines Type Introduction
5.1.1 Cholera
5.1.2 Hepatitis B
5.1.3 Diphtheria
5.1.3 Tetanus
5.1.4 Measles Vaccine
5.1.5 Hepatitis A
5.1.6 Live Attenuated Influenza Vaccine
5.1.7 Polio Vaccine
5.1.8 Rabies Vaccine
5.2 Global Vaccines Sales by Application 2016-2021
5.3 Global Vaccines Revenue by Application 2016-2021
5.4 Global Vaccines Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Vaccines Market by Region
6.1.1 Global Vaccines Sales by Regions
6.1.2 Global Vaccines Revenue by Regions
6.2 North America Vaccines Market 2016-2021
6.3 Europe Vaccines Market 2016-2021
6.4 Asia Pacific Vaccines Market 2016-2021
6.5 South America Vaccines Market 2016-2021
6.6 Middle East and Africa Vaccines Market 2016-2021

7 North America
7.1 North America Vaccines Market by Country 2016-2021
7.1.1 North America Vaccines Sales by Country
7.1.2 North America Vaccines Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Vaccines Market by Country 2016-2021
8.1.1 Europe Vaccines Sales by Country
8.1.2 Europe Vaccines Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Vaccines Market by Country 2016-2021
9.1.1 Asia Pacific Vaccines Sales by Country
9.1.2 Asia Pacific Vaccines Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Vaccines Market by Country 2016-2021
10.1.1 South America Vaccines Sales by Country
10.1.2 South America Vaccines Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Vaccines Market by Country 2016-2021
11.1.1 Middle East and Africa Vaccines Sales by Country
11.1.2 Middle East and Africa Vaccines Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 GSK
12.1.1 GSK Company Information
12.1.2 GSK Vaccines Product Portfolio, Specification and Application
12.1.3 GSK Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 GSK Key Development
12.2 Tiantan
12.2.1 Tiantan Company Information
12.2.2 Tiantan Vaccines Product Portfolio, Specification and Application
12.2.3 Tiantan Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Tiantan Key Development
12.3 Sanofi
12.3.1 Sanofi Company Information
12.3.2 Sanofi Vaccines Product Portfolio, Specification and Application
12.3.3 Sanofi Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Sanofi Key Development
12.4 Pfizer
12.4.1 Pfizer Company Information
12.4.2 Pfizer Vaccines Product Portfolio, Specification and Application
12.4.3 Pfizer Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Pfizer Key Development
12.5 Novartis(GSK)
12.5.1 Novartis(GSK) Company Information
12.5.2 Novartis(GSK) Vaccines Product Portfolio, Specification and Application
12.5.3 Novartis(GSK) Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Novartis(GSK) Key Development
12.6 Merck
12.6.1 Merck Company Information
12.6.2 Merck Vaccines Product Portfolio, Specification and Application
12.6.3 Merck Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Merck Key Development
12.7 MedImmune LLC
12.7.1 MedImmune LLC Company Information
12.7.2 MedImmune LLC Vaccines Product Portfolio, Specification and Application
12.7.3 MedImmune LLC Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Merck Key Development
12.9 Jintan
12.9.1 Jintan Company Information
12.9.2 Jintan Vaccines Product Portfolio, Specification and Application
12.9.3 Jintan Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 Jintan Key Development
12.8 Kangtai
12.8.1 Kangtai Company Information
12.8.2 Kangtai Vaccines Product Portfolio, Specification and Application
12.8.3 Kangtai Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Kangtai Key Development
12.11 Hualan
12.11.1 Hualan Company Information
12.11.2 Hualan Vaccines Product Portfolio, Specification and Application
12.11.3 Hualan Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Hualan Key Development
12.12 Hissen
12.12.1 Hissen Company Information
12.12.2 Hissen Vaccines Product Portfolio, Specification and Application
12.12.3 Hissen Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Hissen Key Development
12.13 CSL
12.13.1 CSL Company Information
12.13.2 CSL Vaccines Product Portfolio, Specification and Application
12.13.3 CSL Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 CSL Key Development
12.14 China National Biotec
12.14.1 China National Biotec Company Information
12.14.2 China National Biotec Vaccines Product Portfolio, Specification and Application
12.14.3 China National Biotec Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 China National Biotec Key Development

13 Global Vaccines Market Forecast by Region by Type and by Application
13.1 Global Vaccines Sales, Revenue Forecast 2022-2027
13.2 Global Vaccines Forecast by Regions
13.2.1 Global Vaccines Sales Forecast by Region 2022-2027
13.2.2 Global Vaccines Revenue Forecast by Region 2022-2027
13.3 Global Vaccines Forecast by Type
13.3.1 Global Vaccines Sales Forecast by Type 2022-2027
13.3.2 Global Vaccines Revenue Forecast by Type 2022-2027
13.3.3 Global Vaccines Price Forecast by Type 2022-2027
13.4 Global Vaccines Forecast by Application
13.4.1 Global Vaccines Sales Forecast by Application 2022-2027
13.4.2 Global Vaccines Revenue Forecast by Application 2022-2027
13.4.3 Global Vaccines Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Vaccines Production Specifications
Table 2: Drivers in Vaccines Market
Table 3: Restraints Vaccines Market
Table 4: Opportunity in Vaccines Market
Table 5: Comparion of Alternative and Vaccines
Table 6: Vaccines Raw Materials Key Suppliers List
Table 7: Vaccines Distributors List
Table 8: Vaccines Major Buyers in Application One
Table 9: Vaccines Major Buyers in Application Two
Table 10: Vaccines Major Buyers in Application Three
Table 11: Global Vaccines Sales (K Units) by Type 2016-2021
Table 12: Global Vaccines Sales Market Share by Type 2016-2021
Table 13: Global Vaccines Revenue (Million USD) by Type 2016-2021
Table 14: Global Vaccines Revenue Market Share by Type 2016-2021
Table 15: Global Vaccines Price by Type 2016-2021
Table 16: Global Vaccines Sales (K Units) by Application 2016-2021
Table 17: Global Vaccines Sales Market Share by Application 2016-2021
Table 18: Global Vaccines Revenue (Million USD) by Application 2016-2021
Table 19: Global Vaccines Revenue Market Share by Application 2016-2021
Table 20: Global Vaccines Price by Application 2016-2021
Table 21: Global Vaccines Sales (K Units) by Region 2016-2021
Table 22: Global Vaccines Sales Market Share by Region 2016-2021
Table 23: Global Vaccines Revenue (Million USD) by Region 2016-2021
Table 24: Global Vaccines Revenue Market Share by Region 2016-2021
Table 25: North America Vaccines Sales (K Units) by Country 2016-2021
Table 26: North America Vaccines Sales Market Share by Country 2016-2021
Table 27: North America Vaccines Revenue (Million USD) by Country 2016-2021
Table 28: North America Vaccines Revenue Market Share by Country 2016-2021)
Table 29: Europe Vaccines Sales (K Units) by Country 2016-2021
Table 30: Europe Vaccines Sales Market Share by Country 2016-2021
Table 31: Europe Vaccines Revenue (Million USD) by Country 2016-2021
Table 32: Europe Vaccines Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Vaccines Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Vaccines Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Vaccines Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Vaccines Revenue Market Share by Country 2016-2021)
Table 37: South America Vaccines Sales (K Units) by Country 2016-2021
Table 38: South America Vaccines Sales Market Share by Country 2016-2021
Table 39: South America Vaccines Revenue (Million USD) by Country 2016-2021
Table 40: South America Vaccines Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Vaccines Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Vaccines Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Vaccines Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Vaccines Revenue Market Share by Country 2016-2021)
Table 45 GSK Company Information
Table 46 GSK Vaccines Product Portfolio, Specification and Application
Table 47 GSK Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Tiantan Company Information
Table 49 Tiantan Vaccines Product Portfolio, Specification and Application
Table 50 Tiantan Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Sanofi Company Information
Table 52 Sanofi Vaccines Product Portfolio, Specification and Application
Table 53 Sanofi Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Pfizer Company Information
Table 55 Pfizer Vaccines Product Portfolio, Specification and Application
Table 56 Pfizer Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Novartis(GSK) Company Information
Table 58 Novartis(GSK) Vaccines Product Portfolio, Specification and Application
Table 59 Novartis(GSK) Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Merck Company Information
Table 61 Merck Vaccines Product Portfolio, Specification and Application
Table 62 Merck Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 MedImmune LLC Company Information
Table 64 MedImmune LLC Vaccines Product Portfolio, Specification and Application
Table 65 MedImmune LLC Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Kangtai Company Information
Table 67 Kangtai Vaccines Product Portfolio, Specification and Application
Table 68 Kangtai Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 Jintan Company Information
Table 70 Jintan Vaccines Product Portfolio, Specification and Application
Table 71 Jintan Vaccines Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Vaccines Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Vaccines Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Vaccines Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Vaccines Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Vaccines Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Vaccines Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Vaccines Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Vaccines Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Vaccines Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Vaccines Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Vaccines Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Vaccines Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Vaccines Picture
Figure 2: Global Vaccines Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Vaccines Supply Chain Analysis
Figure 5: Vaccines Manufacturing Cost Structure Analysis
Figure 6: Product Picture of Recombinant Vaccines
Figure 7: Product Picture of Viral Vaccines
Figure 8: Global Vaccines Sales Market Share by Type, 2020
Figure 9: Global Vaccines Revenue Market Share by Type, 2020
Figure 10: Vaccines in Cholera
Figure 11: Global Vaccines Market: Cholera 2016-2021
Figure 12: Vaccines in Hepatitis B
Figure 13: Global Vaccines Market: Hepatitis B 2016-2021
Figure 14: Global Vaccines Sales Market Share by Application, 2020
Figure 15: Global Vaccines Revenue Market Share by Application, 2020
Figure 16: Global Vaccines Sales Market Share by Region 2016-2021
Figure 17: Global Vaccines Revenue Market Share by Region 2016-2021
Figure 18: North America Vaccines Sales (K Units) Status 2016-2021
Figure 19: North America Vaccines Revenue (Million USD) Status 2016-2021
Figure 20: Europe Vaccines Sales (K Units) Status 2016-2021
Figure 21: Europe Vaccines Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Vaccines Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Vaccines Revenue (Million USD) Status 2016-2021
Figure 24: South America Vaccines Sales (K Units) Status 2016-2021
Figure 25: South America Vaccines Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Vaccines Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Vaccines Revenue (Million USD) Status 2016-2021
Figure 28: North America Vaccines Sales Market Share by Country, 2020
Figure 29: North America Vaccines Revenue Market Share by Country, 2020
Figure 30: United States Vaccines Sales (K Units) Status 2016-2021
Figure 31: United States Vaccines Revenue (Million USD) Status 2016-2021
Figure 32: Canada Vaccines Sales (K Units) Status 2016-2021
Figure 33: Canada Vaccines Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Vaccines Sales (K Units) Status 2016-2021
Figure 35: Mexico Vaccines Revenue (Million USD) Status 2016-2021
Figure 36: Europe Vaccines Sales Market Share by Country, 2020
Figure 37: Europe Vaccines Revenue Market Share by Country, 2020
Figure 38: Germany Vaccines Sales (K Units) Status 2016-2021
Figure 39: Germany Vaccines Revenue (Million USD) Status 2016-2021
Figure 40: France Vaccines Sales (K Units) Status 2016-2021
Figure 41: France Vaccines Revenue (Million USD) Status 2016-2021
Figure 42: UK Vaccines Sales (K Units) Status 2016-2021
Figure 43: UK Vaccines Revenue (Million USD) Status 2016-2021
Figure 44: Italy Vaccines Sales (K Units) Status 2016-2021
Figure 45: Italy Vaccines Revenue (Million USD) Status 2016-2021
Figure 46: Russia Vaccines Sales (K Units) Status 2016-2021
Figure 46: Russia Vaccines Revenue (Million USD) Status 2016-2021
Figure 47: Spain Vaccines Sales (K Units) Status 2016-2021
Figure 48: Spain Vaccines Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Vaccines Sales Market Share by Country, 2020
Figure 50: Asia Pacific Vaccines Revenue Market Share by Country, 2020
Figure 51: China Vaccines Sales (K Units) Status 2016-2021
Figure 52: China Vaccines Revenue (Million USD) Status 2016-2021
Figure 53: Japan Vaccines Sales (K Units) Status 2016-2021
Figure 54: Japan Vaccines Revenue (Million USD) Status 2016-2021
Figure 55: Korea Vaccines Sales (K Units) Status 2016-2021
Figure 56: Korea Vaccines Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Vaccines Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Vaccines Revenue (Million USD) Status 2016-2021
Figure 59: India Vaccines Sales (K Units) Status 2016-2021
Figure 60: India Vaccines Revenue (Million USD) Status 2016-2021
Figure 61: Australia Vaccines Sales (K Units) Status 2016-2021
Figure 62: Australia Vaccines Revenue (Million USD) Status 2016-2021
Figure 63: South America Vaccines Sales Market Share by Country, 2020
Figure 64: South America Vaccines Revenue Market Share by Country, 2020
Figure 65: Brazil Vaccines Sales (K Units) Status 2016-2021
Figure 66: Brazil Vaccines Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Vaccines Sales (K Units) Status 2016-2021
Figure 68: Argentina Vaccines Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Vaccines Sales (K Units) Status 2016-2021
Figure 70: Colombia Vaccines Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Vaccines Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Vaccines Revenue Market Share by Country, 2020
Figure 73: Turkey Vaccines Sales (K Units) Status 2016-2021
Figure 74: Turkey Vaccines Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Vaccines Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Vaccines Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Vaccines Sales (K Units) Status 2016-2021
Figure 78: South Africa Vaccines Revenue (Million USD) Status 2016-2021
Figure 79: GSK Vaccines Revenue Market Share Globally (2019-2021)
Figure 80: Tiantan Vaccines Revenue Market Share Globally (2019-2021)
Figure 81: Sanofi Vaccines Revenue Market Share Globally (2019-2021)
Figure 82: Pfizer Vaccines Revenue Market Share Globally (2019-2021)
Figure 83: Novartis(GSK) Vaccines Revenue Market Share Globally (2019-2021)
Figure 84: Merck Vaccines Revenue Market Share Globally (2019-2021)
Figure 85: MedImmune LLC Vaccines Revenue Market Share Globally (2019-2021)
Figure 86: Kangtai Vaccines Revenue Market Share Globally (2019-2021)
Figure 87: Jintan Vaccines Revenue Market Share Globally (2019-2021)
Figure 88: J&J(Crucell) Vaccines Revenue Market Share Globally (2019-2021)
Figure 89: Global Vaccines Sales (K Units) Forecast (2022-2027)
Figure 90: Global Vaccines Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets